Literature DB >> 25413954

The clinical spectrum of inherited diseases involved in the synthesis and remodeling of complex lipids. A tentative overview.

Àngels Garcia-Cazorla1, Fanny Mochel, Foudil Lamari, Jean-Marie Saudubray.   

Abstract

Over one hundred diseases related to inherited defects of complex lipids synthesis and remodeling are now reported. Most of them were described within the last 5 years. New descriptions and phenotypes are expanding rapidly. While the associated clinical phenotype is currently difficult to outline, with only a few patients identified, it appears that all organs and systems may be affected. The main clinical presentations can be divided into (1) Diseases affecting the central and peripheral nervous system. Complex lipid synthesis disorders produce prominent motor manifestations due to upper and/or lower motoneuron degeneration. Motor signs are often complex, associated with other neurological and extra-neurological signs. Three neurological phenotypes, spastic paraparesis, neurodegeneration with brain iron accumulation and peripheral neuropathies, deserve special attention. Many apparently well clinically defined syndromes are not distinct entities, but rather clusters on a continuous spectrum, like for the PNPLA6-associated diseases, extending from Boucher-Neuhauser syndrome via Gordon Holmes syndrome to spastic ataxia and pure hereditary spastic paraplegia; (2) Muscular/cardiac presentations; (3) Skin symptoms mostly represented by syndromic (neurocutaneous) and non syndromic ichthyosis; (4) Retinal dystrophies with syndromic and non syndromic retinitis pigmentosa, Leber congenital amaurosis, cone rod dystrophy, Stargardt disease; (5) Congenital bone dysplasia and segmental overgrowth disorders with congenital lipomatosis; (6) Liver presentations characterized mainly by transient neonatal cholestatic jaundice and non alcoholic liver steatosis with hypertriglyceridemia; and (7) Renal and immune presentations. Lipidomics and molecular functional studies could help to elucidate the mechanism(s) of dominant versus recessive inheritance observed for the same gene in a growing number of these disorders.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25413954     DOI: 10.1007/s10545-014-9776-6

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  165 in total

1.  Mutations in a new cytochrome P450 gene in lamellar ichthyosis type 3.

Authors:  Caroline Lefèvre; Bakar Bouadjar; Véronique Ferrand; Gianluca Tadini; André Mégarbané; Mark Lathrop; Jean-François Prud'homme; Judith Fischer
Journal:  Hum Mol Genet       Date:  2006-01-25       Impact factor: 6.150

2.  Mutations in a delta 8-delta 7 sterol isomerase in the tattered mouse and X-linked dominant chondrodysplasia punctata. jderry@immunex.com.

Authors:  J M Derry; E Gormally; G D Means; W Zhao; A Meindl; R I Kelley; Y Boyd; G E Herman
Journal:  Nat Genet       Date:  1999-07       Impact factor: 38.330

3.  Mutations in CGI-58, the gene encoding a new protein of the esterase/lipase/thioesterase subfamily, in Chanarin-Dorfman syndrome.

Authors:  C Lefèvre; F Jobard; F Caux; B Bouadjar; A Karaduman; R Heilig; H Lakhdar; A Wollenberg; J L Verret; J Weissenbach; M Ozgüc; M Lathrop; J F Prud'homme; J Fischer
Journal:  Am J Hum Genet       Date:  2001-10-02       Impact factor: 11.025

4.  Mutations in PIGO, a member of the GPI-anchor-synthesis pathway, cause hyperphosphatasia with mental retardation.

Authors:  Peter M Krawitz; Yoshiko Murakami; Jochen Hecht; Ulrike Krüger; Susan E Holder; Geert R Mortier; Barbara Delle Chiaie; Elfride De Baere; Miles D Thompson; Tony Roscioli; Szymon Kielbasa; Taroh Kinoshita; Stefan Mundlos; Peter N Robinson; Denise Horn
Journal:  Am J Hum Genet       Date:  2012-06-07       Impact factor: 11.025

5.  Long-chain 3-hydroxyacylCoA dehydrogenase deficiency: a new case presenting with liver dysfunction, cholestasis and fibrosis.

Authors:  M H Odievre; C Sevin; J Laurent; J P Laboureau; D Rabier; M Brivet; C Roe; R J A Wanders; J M Saudubray
Journal:  Acta Paediatr       Date:  2002       Impact factor: 2.299

6.  A homozygous missense mutation in the IRBP gene (RBP3) associated with autosomal recessive retinitis pigmentosa.

Authors:  Anneke I den Hollander; Terri L McGee; Carmela Ziviello; Sandro Banfi; Thaddeus P Dryja; Federico Gonzalez-Fernandez; Debashis Ghosh; Eliot L Berson
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-12-13       Impact factor: 4.799

Review 7.  Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms.

Authors:  John K Fink
Journal:  Acta Neuropathol       Date:  2013-07-30       Impact factor: 17.088

8.  Exome sequence reveals mutations in CoA synthase as a cause of neurodegeneration with brain iron accumulation.

Authors:  Sabrina Dusi; Lorella Valletta; Tobias B Haack; Yugo Tsuchiya; Paola Venco; Sebastiano Pasqualato; Paola Goffrini; Marco Tigano; Nikita Demchenko; Thomas Wieland; Thomas Schwarzmayr; Tim M Strom; Federica Invernizzi; Barbara Garavaglia; Allison Gregory; Lynn Sanford; Jeffrey Hamada; Conceição Bettencourt; Henry Houlden; Luisa Chiapparini; Giovanna Zorzi; Manju A Kurian; Nardo Nardocci; Holger Prokisch; Susan Hayflick; Ivan Gout; Valeria Tiranti
Journal:  Am J Hum Genet       Date:  2013-12-19       Impact factor: 11.025

9.  PNPLA1 mutations cause autosomal recessive congenital ichthyosis in golden retriever dogs and humans.

Authors:  Anaïs Grall; Eric Guaguère; Sandrine Planchais; Susanne Grond; Emmanuelle Bourrat; Ingrid Hausser; Christophe Hitte; Matthieu Le Gallo; Céline Derbois; Gwang-Jin Kim; Laëtitia Lagoutte; Frédérique Degorce-Rubiales; Franz P W Radner; Anne Thomas; Sébastien Küry; Emmanuel Bensignor; Jacques Fontaine; Didier Pin; Robert Zimmermann; Rudolf Zechner; Mark Lathrop; Francis Galibert; Catherine André; Judith Fischer
Journal:  Nat Genet       Date:  2012-01-15       Impact factor: 38.330

10.  Mutations in CERS3 cause autosomal recessive congenital ichthyosis in humans.

Authors:  Franz P W Radner; Slaheddine Marrakchi; Peter Kirchmeier; Gwang-Jin Kim; Florence Ribierre; Bourane Kamoun; Leila Abid; Michael Leipoldt; Hamida Turki; Werner Schempp; Roland Heilig; Mark Lathrop; Judith Fischer
Journal:  PLoS Genet       Date:  2013-06-06       Impact factor: 5.917

View more
  15 in total

1.  Clinical characteristics of megaconial congenital muscular dystrophy due to choline kinase beta gene defects in a series of 15 patients.

Authors:  Goknur Haliloglu; Beril Talim; Cigdem Genc Sel; Haluk Topaloglu
Journal:  J Inherit Metab Dis       Date:  2015-06-12       Impact factor: 4.982

2.  Think big - think omics.

Authors:  Ron A Wevers; Nenad Blau
Journal:  J Inherit Metab Dis       Date:  2018-05       Impact factor: 4.982

Review 3.  Lipids and synaptic functions.

Authors:  Fanny Mochel
Journal:  J Inherit Metab Dis       Date:  2018-06-04       Impact factor: 4.982

4.  miRNAexpression profile of retinal pigment epithelial cells under oxidative stress conditions.

Authors:  Luigi Donato; Placido Bramanti; Concetta Scimone; Carmela Rinaldi; Sarka Beranova-Giorgianni; Diwa Koirala; Rosalia D'Angelo; Antonina Sidoti
Journal:  FEBS Open Bio       Date:  2018-01-02       Impact factor: 2.693

5.  Retinal de novo lipogenesis coordinates neurotrophic signaling to maintain vision.

Authors:  Rithwick Rajagopal; Sheng Zhang; Xiaochao Wei; Teresa Doggett; Sangeeta Adak; Jennifer Enright; Vaishali Shah; Guoyu Ling; Shiming Chen; Jun Yoshino; Fong-Fu Hsu; Clay F Semenkovich
Journal:  JCI Insight       Date:  2018-01-11

Review 6.  An overview of inborn errors of metabolism affecting the brain: from neurodevelopment to neurodegenerative disorders.

Authors:  Jean-Marie Saudubray; Angela Garcia-Cazorla
Journal:  Dialogues Clin Neurosci       Date:  2018-12       Impact factor: 5.986

7.  Transient neonatal renal failure and massive polyuria in MEGDEL syndrome.

Authors:  Carole Harbulot; Stéphanie Paquay; Imen Dorboz; Samia Pichard; Agnès Bourillon; Jean-François Benoist; Claude Jardel; Hélène Ogier de Baulny; Odile Boespflug-Tanguy; Manuel Schiff
Journal:  Mol Genet Metab Rep       Date:  2016-03-10

8.  QIL1 mutation causes MICOS disassembly and early onset fatal mitochondrial encephalopathy with liver disease.

Authors:  Virginia Guarani; Claude Jardel; Dominique Chrétien; Anne Lombès; Paule Bénit; Clémence Labasse; Emmanuelle Lacène; Agnès Bourillon; Apolline Imbard; Jean-François Benoist; Imen Dorboz; Mylène Gilleron; Eric S Goetzman; Pauline Gaignard; Abdelhamid Slama; Monique Elmaleh-Bergès; Norma B Romero; Pierre Rustin; Hélène Ogier de Baulny; Joao A Paulo; J Wade Harper; Manuel Schiff
Journal:  Elife       Date:  2016-09-13       Impact factor: 8.140

9.  Progressive deafness-dystonia due to SERAC1 mutations: A study of 67 cases.

Authors:  Roeltje R Maas; Katarzyna Iwanicka-Pronicka; Sema Kalkan Ucar; Bader Alhaddad; Moeenaldeen AlSayed; Mohammed A Al-Owain; Hamad I Al-Zaidan; Shanti Balasubramaniam; Ivo Barić; Dalal K Bubshait; Alberto Burlina; John Christodoulou; Wendy K Chung; Roberto Colombo; Niklas Darin; Peter Freisinger; Maria Teresa Garcia Silva; Stephanie Grunewald; Tobias B Haack; Peter M van Hasselt; Omar Hikmat; Friederike Hörster; Pirjo Isohanni; Khushnooda Ramzan; Reka Kovacs-Nagy; Zita Krumina; Elena Martin-Hernandez; Johannes A Mayr; Patricia McClean; Linda De Meirleir; Karin Naess; Lock H Ngu; Magdalena Pajdowska; Shamima Rahman; Gillian Riordan; Lisa Riley; Benjamin Roeben; Frank Rutsch; Rene Santer; Manuel Schiff; Martine Seders; Silvia Sequeira; Wolfgang Sperl; Christian Staufner; Matthis Synofzik; Robert W Taylor; Joanna Trubicka; Konstantinos Tsiakas; Ozlem Unal; Evangeline Wassmer; Yehani Wedatilake; Toni Wolff; Holger Prokisch; Eva Morava; Ewa Pronicka; Ron A Wevers; Arjan P de Brouwer; Saskia B Wortmann
Journal:  Ann Neurol       Date:  2017-12       Impact factor: 10.422

10.  Disease-Associated PNPLA6 Mutations Maintain Partial Functions When Analyzed in Drosophila.

Authors:  Elizabeth R Sunderhaus; Alexander D Law; Doris Kretzschmar
Journal:  Front Neurosci       Date:  2019-11-06       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.